SCHEMBL7716113

SCHEMBL7716113

COC(=O)c1ccc2c(c1)CCC(=O)C1=C2CCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 1/20 0.46
SRD5A1 P18405 3/20 0.45
SRD5A2 P31213 3/20 0.45
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
ATM Q13315 1/20 0.43
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
FGB P02675 1/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPK14 Q16539 3/20 0.42
BAZ2B Q9UIF8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31532073 0.88 SRD5A1 (0.51) PTPRCSRD5A1SRD5A2ALDH1A1SMN1; SMN2
SCHEMBL883773 0.88 SRD5A1 (0.51) PTPRCSRD5A1SRD5A2ALDH1A1SMN1; SMN2
SCHEMBL353895 0.85 BAZ2B (0.56) PTPRCSRD5A1SRD5A2ALDH1A1SMN1; SMN2
SCHEMBL13727452 0.82 BAZ2B (0.52) PTPRCSRD5A1SRD5A2ALDH1A1SMN1; SMN2
SCHEMBL5204433 0.82 SRD5A2 (0.55) PTPRCSRD5A1SRD5A2ALDH1A1HSP90AA1
SCHEMBL13548832 0.81 MAPK14 (0.56) PTPRCSRD5A1SRD5A2ALDH1A1SMN1; SMN2
SCHEMBL484748 0.76 PBRM1 (0.51) PTPRCSRD5A1SRD5A2ALDH1A1SMN1; SMN2
SCHEMBL16499680 0.75 PTPRC (0.46) PTPRCSRD5A1SRD5A2ALDH1A1SMN1; SMN2
SCHEMBL26187743 0.75 ALDH1A1 (0.44) PTPRCSRD5A1SRD5A2ALDH1A1SMN1; SMN2
SCHEMBL8142034 0.74 SRD5A1 (0.56) PTPRCSRD5A1SRD5A2ALDH1A1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6339082-B1 FOR THERAPY OF DISEASES CAUSED BY LOSS OF BONE MATRIX AVENTIS PHARMA S.A. (FR) 2002-01-15 US disclosed